Gene · 1540
Papers3,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network-level reprogramming of cell death pathways in colorectal cancer cells by combined thymoquinone and 5-fluorouracil treatment. | Front Mol Biosci | 2026 | 42422877 | PubTator, text mining | PubMed |
| Genomic Profiling of Breast Cancer in an Ecuadorian Cohort Reveals Clinically Relevant Variants and Ancestry-Related Interpretation Challenges. | Cancers (Basel) | 2026 | 42352496 | PubTator, text mining | PubMed |
| Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li-Fraumeni syndrome. | Histopathology | 2026 | 42312930 | PubTator, text mining | PubMed |
| Multi-omics profiling characterizes the primary cilium-related molecular regulatory landscape in systemic lupus erythematosus. | Analyst | 2026 | 42312723 | PubTator, text mining | PubMed |
| Caution in interpreting in vitro studies of CYLD variants. | J Invest Dermatol | 2026 | 42288148 | PubTator, text mining | PubMed |
| Extracellular vesicle-encapsulated miRNAs mediate monocyte-endothelial cell crosstalk to exacerbate renal injury in diabetic kidney disease. | Int Immunopharmacol | 2026 | 42275918 | PubTator, text mining | PubMed |
| Global Geo-Pharmacogenomics: Environmental Mutational Signatures Drive Population-Level Heterogeneity in Anticancer Drug Response. | J Xenobiot | 2026 | 42201082 | PubTator, text mining | PubMed |
| Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy. | J Immunother Cancer | 2026 | 42156138 | PubTator, text mining | PubMed |
| Systematic discovery of motif-based interactions of the auxiliary domains of USP family deubiquitinases. | Nat Commun | 2026 | 42151178 | PubTator, text mining | PubMed |
| High frequency of RB1 mutations p16 positive early stage oropharyngeal carcinoma: A genomic and transcriptomic analysis. | Oral Oncol | 2026 | 42143526 | PubTator, text mining | PubMed |
| The role of e3 ubiquitin ligases and deubiquitinating enzymes in hepatocellular carcinoma. | Cell Biol Toxicol | 2026 | 42105150 | PubTator, text mining | PubMed |
| Recent developments in salivary gland pathology after the WHO 2024 classification: new developments in existing entities and evolving new entities. | Virchows Arch | 2026 | 42032135 | PubTator, text mining | PubMed |
| The deubiquitinase activity of CYLD is required for B cell differentiation. | Cell Death Dis | 2026 | 41951576 | PubTator, text mining | PubMed |
| The Role of A-Kinase Anchoring Proteins for Inhibitory cAMP Signalling in Platelets. | Cells | 2026 | 41892342 | PubTator, text mining | PubMed |
| Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy. | Cancer Immunol Immunother | 2026 | 41843177 | PubTator, text mining | PubMed |
| Helping primary care providers recognize and respond to medication non-adherence and drug-drug interactions: A randomized-controlled clinical utility trial in a value-based care setting. | PLoS One | 2026 | 41838747 | PubTator, text mining | PubMed |
| Activation Efficiency and Restoration Effects of SBS Network-Repairing Regenerators on Aged Asphalt. | Materials (Basel) | 2026 | 41828159 | PubTator, text mining | PubMed |
| Analysis of CYLD gene variants in 41 patients with multiple familial trichoepithelioma. | J Dtsch Dermatol Ges | 2026 | 41810882 | PubTator, text mining | PubMed |
| Effect of Using the External Auditory Canal Skin of the Healthy Side to Treat Unilateral Congenital Aural Atresia: A Randomized Clinical Trial. | Otol Neurotol | 2026 | 41803072 | PubTator, text mining | PubMed |
| Case Report: CYLD cutaneous syndrome with malignant transformation to spiradenocarcinoma: cooperative effects of CYLD truncation and an MSH2 clamp-domain variant in an Ecuadorian patient. | Front Med (Lausanne) | 2026 | 41788709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1540/papers?page=2